Abeona Therapeutics Inc. 0H7R.L Stock
Abeona Therapeutics Inc. Price Chart
Abeona Therapeutics Inc. 0H7R.L Financial and Trading Overview
| Abeona Therapeutics Inc. stock price | 4.56 USD |
| Previous Close | 4.54 USD |
| Open | 0 USD |
| Bid | 0 USD x N/A |
| Ask | 0 USD x N/A |
| Day's Range | 0 - 0 USD |
| 52 Week Range | 0 - 5.85 USD |
| Volume | 143.09K USD |
| Avg. Volume | 965 USD |
| Market Cap | 1.24M USD |
| Beta (5Y Monthly) | 1.261971 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.808 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0H7R.L Valuation Measures
| Enterprise Value | 52.21M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.1577284 |
| Price/Book (mrq) | 4.2352633 |
| Enterprise Value/Revenue | 48.884 |
| Enterprise Value/EBITDA | -1.308 |
Trading Information
Abeona Therapeutics Inc. Stock Price History
| Beta (5Y Monthly) | 1.261971 |
| 52-Week Change | 11.06% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5.85 USD |
| 52 Week Low | 0 USD |
| 50-Day Moving Average | 3.07 USD |
| 200-Day Moving Average | 3.68 USD |
0H7R.L Share Statistics
| Avg. Volume (3 month) | 965 USD |
| Avg. Daily Volume (10-Days) | 1.62K USD |
| Shares Outstanding | 47.94M |
| Float | 13.79M |
| Short Ratio | N/A |
| % Held by Insiders | 2.84% |
| % Held by Institutions | 44.97% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 0.04:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -4014.23% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -49.38% |
| Return on Equity (ttm) | -106.64% |
Income Statement
| Revenue (ttm) | 1.07M USD |
| Revenue Per Share (ttm) | 0.1 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -28001000 USD |
| EBITDA | -39929000 USD |
| Net Income Avi to Common (ttm) | -30541000 USD |
| Diluted EPS (ttm) | -0.808 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 40.36M USD |
| Total Cash Per Share (mrq) | 2.15 USD |
| Total Debt (mrq) | 7.32M USD |
| Total Debt/Equity (mrq) | 39.06 USD |
| Current Ratio (mrq) | 5.774 |
| Book Value Per Share (mrq) | 1.045 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -41540000 USD |
| Levered Free Cash Flow (ttm) | -19601500 USD |
Profile of Abeona Therapeutics Inc.
| Country | United Kingdom |
| State | NY |
| City | New York |
| Address | 1330 Avenue of the Americas |
| ZIP | 10019 |
| Phone | 646 813 4701 |
| Website | https://www.abeonatherapeutics.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 57 |
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 for the treatment of X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 for the treatment of autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. is headquartered in New York, New York.
Q&A For Abeona Therapeutics Inc. Stock
What is a current 0H7R.L stock price?
Abeona Therapeutics Inc. 0H7R.L stock price today per share is 4.56 USD.
How to purchase Abeona Therapeutics Inc. stock?
You can buy 0H7R.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Abeona Therapeutics Inc.?
The stock symbol or ticker of Abeona Therapeutics Inc. is 0H7R.L.
How many shares does Abeona Therapeutics Inc. have in circulation?
The max supply of Abeona Therapeutics Inc. shares is 27.94M.
What is Abeona Therapeutics Inc. Price to Earnings Ratio (PE Ratio)?
Abeona Therapeutics Inc. PE Ratio is now.
What was Abeona Therapeutics Inc. earnings per share over the trailing 12 months (TTM)?
Abeona Therapeutics Inc. EPS is -0.808 USD over the trailing 12 months.